263 results on '"Takehara, Kazuhiko"'
Search Results
2. Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial.
3. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
4. CD22 and CD72 contribute to the development of scleroderma in a murine model
5. GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region
6. Perspective to precision medicine in scleroderma
7. Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies
8. CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model
9. Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells
10. Transforming Growth Factor-ß and Connective Tissue Growth Factor
11. The Role of B Cells in Systemic Sclerosis
12. A case of lymphoma-associated haemophagocytic syndrome in advanced-stage mycosis fungoides
13. RXRB Is an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis
14. Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod
15. Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population
16. GWAS for Systemic Sclerosis Identified six novel susceptibility loci including penetrating Fcγ-Receptor Region
17. A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase–Akt pathway activation
18. A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer
19. A case of anti-RuvBL1/2 antibody-positive systemic sclerosis overlapping with myositis
20. B Cells Promote Tumor Immunity against B16F10 Melanoma
21. ESDR028 - A role for FcγRIIB in systemic sclerosis
22. Food‐dependent exercise‐induced anaphylaxis due to shrimp associated with 43 kDa, a new antigen
23. A case of juvenile localized scleroderma with anti-topoisomerase I antibody
24. Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open‐label study
25. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
26. Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients’ cohort
27. A case of aseptic meningitis without neck rigidity occurring in a metastatic melanoma patient treated with ipilimumab
28. Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III Autoantibodies
29. Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud’s phenomenon
30. Tocilizumab in systemic sclerosis:a randomised, double-blind, placebo-controlled, phase 3 trial
31. A case of anti‐OJ antibody‐positive polymyositis with marked muscle involvement and interstitial lung disease
32. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
33. Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody
34. Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study
35. Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis
36. Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan
37. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study
38. A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor
39. Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial
40. Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study
41. Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models
42. Stevens–Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor
43. Chromoblastomycosis caused by Phialophora verrucosa on the hand
44. Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis
45. Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease
46. Human case of subcutaneous nodule because of a novel genetic variation of Dirofilaria sp.
47. Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients
48. Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy
49. Performance evaluation of a line blot assay system for detection of anti‐PM‐Scl antibody in Japanese patients with systemic sclerosis
50. Successful radiation therapy for primary cutaneous follicle center lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.